RxDoctor Payments Data

Dayvigo: cost and payments to doctors

What Medicare Part D paid pharmacies for Dayvigo, and the payments that named it as the associated drug or biological under the Sunshine Act for program years 20192025.

What Dayvigo costs under Medicare Part D

$321paid to pharmacies per 30-day fill, on average

This is what Part D plans and patients paid pharmacies — not what you would pay, and not money the prescriber received. Your own cost depends on your plan and where you are in your benefit year. It excludes commercial insurance, Medicaid and Part B, and it is before the manufacturer rebates CMS does not publish.

Per 30-day fill
$321

The comparable unit

12 fills
$3,854

A year of therapy, if taken monthly

Prescribers
1,445

With 11+ claims; CMS suppresses fewer

Active ingredient
Lemborexant
Claims (published)
26,294
30-day fills
27,931
Total paid to pharmacies
$8,970,493

Most prescribed by nurse practitioner, psychiatry, internal medicine.

Source: CMS Medicare Part D Prescribers — by Provider and Drug. Totals cover rows CMS published; prescriber-drug pairs with fewer than 11 claims are suppressed and are not counted here.

Was your doctor paid by Eisai Inc.?

Eisai Inc. reported the most payments naming Dayvigo. Search your clinician to see whether they are among them — and what else they were paid for.

Finding a payment is not a finding of wrongdoing — most reported payments are a meal during a presentation. What matters is the kind, the size, and how it compares with their peers, which is what the profile shows.

Total reported
$4.1M
Providers
29,242
Transactions
87,080
Average per transaction
$47

The per-transaction average — $47 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 29,242 providers the average total is $139, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Eisai Inc.$4,016,77998.9%
Eisai Co., Ltd.$43,8731.1%

Other products from Eisai Inc.

The company that reported the most payments naming Dayvigo also reports against these.

← All drugs & devices